glp-1 alcohol cravings agonists help reduce and addiction semaglutide for alcohol cravings Recent

Tirzepatide (Mounjaro) is a dual GIP/GLP-1 receptor agonist currently licensed in the UK for type 2 diabetes only

Its non-peptide structure makes it resistant to stomach acid and digestive enzymes, achieving approximately 79% oral bioavailability compared to less than 1% for oral semaglutide

Effects of dapagliflozin compared with sitagliptin and metformin in drug-nave Japanese patients with type 2 diabetes: A 12-week, open-label, randomized, active-controlled trial

[DOI] [Google Scholar] 65.Huang L, Zeng J, Wang Y, Pollak M

Update to a position statement of the American Diabetes Association and the European Association for the study of diabetes